2021
DOI: 10.1016/j.amsu.2021.102696
|View full text |Cite
|
Sign up to set email alerts
|

Misdiagnosis of persistent asthma of a patient suffering from acute bronchopulmonary aspergillosis (ABPA)

Abstract: Background Allergic bronchopulmonary aspergillosis (ABPA) is a condition characterized by an exaggerated immune response (a hypersensitivity response) to the fungus Aspergillus (most commonly Aspergillus fumigatus ). ABPA causes airway inflammation that if left untreated can lead to bronchiectasis (an abnormal dilation of the airways) due to the immune system and fungal spores damaging sensitive lung tissues and ultimately leading … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 13 publications
0
2
0
Order By: Relevance
“…However, ABPA is a condition characterized by a hypersensitivity response to the fungus Aspergillus (most commonly Aspergillus fumigatus ). Patient may also misdiagnosed as chronic persistent asthma [ 10 ].To our best of knowledge, this is the first study conducted in Pakistan on the misdiagnosis of ABPA with smear negative TB. Our study clearly shows that APBA is still under recognized in the country.…”
Section: Discussionmentioning
confidence: 99%
“…However, ABPA is a condition characterized by a hypersensitivity response to the fungus Aspergillus (most commonly Aspergillus fumigatus ). Patient may also misdiagnosed as chronic persistent asthma [ 10 ].To our best of knowledge, this is the first study conducted in Pakistan on the misdiagnosis of ABPA with smear negative TB. Our study clearly shows that APBA is still under recognized in the country.…”
Section: Discussionmentioning
confidence: 99%
“…In our survey, most respondents (192/267, 71.9%) relied on a combination of clinical, immunological, and radiological criteria to identify ABPA exacerbation, while a small (3%) proportion relied on clinical symptoms only. Poorly controlled asthma resembles ABPA, 127 and distinguishing between the two requires immunological tests and imaging. Also, the reliance on only clinical and radiological criteria (10% of the respondents) is fraught with the risk of overdiagnosing exacerbation since certain radiological changes are persistent (e.g., bronchiectasis).…”
Section: Treatment Of Abpamentioning
confidence: 99%